Conclusion de contrats de coentreprise entre Shangai Zuquan Investment Management Company Limited d’une part et Epygon, Kephalios et MyoPowers d’autre part.
Recent Posts
- Interview with Michel Therin, Chairman of the Board of Directors and Sébastien Ladet, CEO, in the “Actu Bourse” issue on Boursorama
- Affluent Medical signs agreements for mitral valve technologies with EUR 15M upfront payment
- Clinical Product Specialist Structural Heart
- Spécialiste produit – Urologie
- Successful first-in-human implantation of artificial sphincter Artus for the treatment of stress urinary incontinence
Recent Comments